Living With MS: Switching Medications

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

In this video, Lauren Parrot vlogs about multiple sclerosis and her fears about switching her medication from Tysabri to Ocrelizumab.

First potential therapy for primary progressive MS, Ocrelizumab, under priority review by the FDA. Read more.

Lauren’s been taking Tysabri for almost nine years and has been advised to switch to Ocrelizumab because she is JCV positive (John Cunningham’s virus) and at risk of contracting progressive multifocal leukoencephalopathy (PML)–a rare brain disease. Lauren is uncertain of her future with the new treatment and understandably scared about transitioning from one medication to another.

New guidelines for MS patients taking Tysabri for controlling rare brain infection risk. Read more.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.

Listen Here